Posaconazole and Dacogen drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Posaconazole (posaconazole) and Dacogen (decitabine). Common drug interactions include acute myeloid leukaemia among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Posaconazole and Dacogen. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.
What is Posaconazole?
Posaconazole has active ingredients of posaconazole. eHealthMe is studying from 9,475 Posaconazole users. Check the latest studies of Posaconazole.
What is Dacogen?
Dacogen has active ingredients of decitabine. eHealthMe is studying from 1,541 Dacogen users. Check the latest studies of Dacogen.
27 people who take Posaconazole and Dacogen together, and have interactions are studied.

What are the common drug interactions of Posaconazole and Dacogen, by gender? *:
female:
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Drug hypersensitivity
- Lung infection
- Myelodysplastic syndrome transformation (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged and gets changed into rapid progressing cancer)
- Neutropenia (an abnormally low number of neutrophils)
- Oedema peripheral (superficial swelling)
- Oropharyngeal pain
- Pneumonia
- Pyrexia (fever)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
male:
- Drug ineffective
- Septic shock (shock due to blood infection)
- Cardiac failure congestive
- Pyrexia (fever)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Atrioventricular block (heart block)
- Bradycardia (abnormally slow heart action)
- Cardioactive drug level increased
- Transplant
- Blast cell crisis
What are the common drug interactions of Posaconazole and Dacogen, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Transplant
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
50-59:
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Drug hypersensitivity
- Lung infection
- Myelodysplastic syndrome transformation (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged and gets changed into rapid progressing cancer)
- Neutropenia (an abnormally low number of neutrophils)
- Oedema peripheral (superficial swelling)
- Oropharyngeal pain
- Pyrexia (fever)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Stem cell transplant
60+:
- Neutropenia (an abnormally low number of neutrophils)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Abscess fungal (pus produced by a fungal infection)
- Blast cell crisis
- Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
- C-reactive protein increased
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Dizziness
- Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
- Fatigue (feeling of tiredness)
What are the existing conditions these people have? *
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 18 people, 66.67%
- Cardiac Failure Congestive: 5 people, 18.52%
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 11.11%
- Febrile Neutropenia (fever with reduced white blood cells): 3 people, 11.11%
- Chronic Myelomonocytic Leukaemia (cancers of the blood-forming cells of the bone marrow): 2 people, 7.41%
- Bone Marrow Conditioning Regimen: 2 people, 7.41%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 7.41%
* Approximation only. Some reports may have incomplete information.
Do you take Posaconazole and Dacogen?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Posaconazole (9,475 reports)
- Dacogen (1,541 reports)
Browse all drug interactions of Posaconazole and Dacogen:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Posaconazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Dacogen:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Posaconazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dacogen and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on posaconazole and decitabine (the active ingredients of Posaconazole and Dacogen, respectively), and Posaconazole and Dacogen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Aranesp cause Nephrogenic Fibrosing Dermopathy? - 6 seconds ago
- Ischaemia and Insomnia - 9 seconds ago
- Could Xarelto cause Femoral Neck Fracture? - 10 seconds ago
- Drug interactions of Amaryl and Oxybutynin Chloride - 10 seconds ago
- Could Glucosamine Sulfate cause Dry Skin? - 10 seconds ago
- Could Synthroid cause Sinus Pain? - 18 seconds ago
- Cardiac Failure Congestive and Muscle Disorder - 23 seconds ago
- Drug interactions of Indomethacin and Eletriptan Hydrobromide - 27 seconds ago
- Nightmares and Back Pain - 34 seconds ago
- Drug interactions of Micardis and Naproxen - 37 seconds ago